Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases
Phase 1/2
46
about 3.8 years
18+
1 site in FL
About this study
This trial is testing a treatment with azeliragon and stereotactic radiation therapy for brain metastases. The goal is to see if this combination improves tumor shrinking and keeps tumors controlled longer.
Based on ClinicalTrials.gov records.
What participants do
- 1.Receive Stereotactic radiosurgery
- 2.Take Azeliragon
- 3.Take Corticosteroid
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
corticosteroid
Secondary: CNS treatment-related adverse events, Change in QOL using EORTC QLQ-BN20, Change in patient-reported outcomes (PROs), Change in quality of life (QOL) using EORTC QLQ-C30, Early brain metastases response rate, Intracranial objective response rate
radiation
Oncology